Art
J-GLOBAL ID:201402269390018429   Reference number:14A1475419

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma

肝細胞癌に対するソラフェニブへの治療後応答評価のためのシステムの比較
Author (13):
Material:
Volume: 49  Issue: 12  Page: 1578-1587  Publication year: Dec. 2014 
JST Material Number: Z0748A  ISSN: 0944-1174  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1475419&from=J-GLOBAL&jstjournalNo=Z0748A") }}
JST classification (4):
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of digestive system  ,  Drug therapy(=pharmacotherapy)for tumors  ,  Clinical application of antitumor(=antineoplastic)drugs  ,  Liver 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (15):
  • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-76.
  • Llovet JM, Ricci S, Mazzaferro V, et al. SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378-90.
  • Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis. Oncology. 2011;81:24-9.
  • Wilhelm SM, Adnane L, Newell P, et al. Preclinical overview of sorafenib, a multikinase inhibitor that targets both RAF and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7:3129-40.
  • Rini BI. Sorafenib. Expert Opin Pharmacother. 2006;7:453-61.
more...
Terms in the title (5):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page